TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+10.67%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$735M
AUM Growth
–
Cap. Flow
+$735M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
55.66%
Holding
60
New
60
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$77.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$62.9M |
| 3 |
CELG
Celgene Corp
CELG
|
$59.6M |
| 4 |
Biogen
BIIB
|
$41.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$36.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 84.4% |
| 2 | Financials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
26
Amarin Corp
AMRN
$311M
| $7.9M | 1.07% |
+1,362,298
| New | +$7.9M |
|
|
AGN
27
DELISTED
ALLERGAN INC
AGN
| $7.84M | 1.07% |
+93,077
| New | +$7.84M |
|
28
Illumina
ILMN
$15.2B
| $7.77M | 1.06% |
+103,841
| New | +$7.77M |
|
|
ALR
29
DELISTED
Alere Inc
ALR
| $7.76M | 1.05% |
+316,553
| New | +$7.76M |
|
30
Ironwood Pharmaceuticals
IRWD
$201M
| $7.64M | 1.04% |
+768,050
| New | +$7.64M |
|
|
ARIA
31
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $7.22M | 0.98% |
+412,965
| New | +$7.22M |
|
|
IPXL
32
DELISTED
Impax Laboratories, Inc.
IPXL
| $6.88M | 0.94% |
+344,683
| New | +$6.88M |
|
|
IMGN
33
DELISTED
Immunogen Inc
IMGN
| $6.53M | 0.89% |
+393,773
| New | +$6.53M |
|
34
McKesson
MCK
$85.9B
| $6.51M | 0.89% |
+56,862
| New | +$6.51M |
|
|
FRX
35
DELISTED
FOREST LABORATORIES INC
FRX
| $6.01M | 0.82% |
+146,500
| New | +$6.01M |
|
|
SGNT
36
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $5.67M | 0.77% |
+270,031
| New | +$5.67M |
|
37
Alkermes
ALKS
$4.95B
| $5.59M | 0.76% |
+194,870
| New | +$5.59M |
|
38
UnitedHealth
UNH
$279B
| $5.4M | 0.73% |
+82,436
| New | +$5.4M |
|
39
Baxter International
BAX
$12.1B
| $5.38M | 0.73% |
+77,675
| New | +$5.38M |
|
40
Idexx Laboratories
IDXX
$50.7B
| $5.05M | 0.69% |
+56,265
| New | +$5.05M |
|
|
ENDP
41
DELISTED
Endo International plc
ENDP
| $4.64M | 0.63% |
+126,215
| New | +$4.64M |
|
42
Accuray
ARAY
$165M
| $4.2M | 0.57% |
+731,943
| New | +$4.2M |
|
43
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.18M | 0.57% |
+75,000
| New | +$4.18M |
|
44
CVS Health
CVS
$93B
| $4.09M | 0.56% |
+71,591
| New | +$4.09M |
|
|
ACOR
45
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $3.72M | 0.51% |
+112,881
| New | +$3.72M |
|
|
MACK
46
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.62M | 0.49% |
+537,600
| New | +$3.62M |
|
|
ELN
47
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| $3.43M | 0.47% |
+242,500
| New | +$3.43M |
|
|
IPCI
48
DELISTED
Intellipharmaceuticals International Inc.
IPCI
| $2.81M | 0.38% |
+1,735,000
| New | +$2.81M |
|
49
Rigel Pharmaceuticals
RIGL
$710M
| $2.76M | 0.38% |
+827,100
| New | +$2.76M |
|
|
AUXL
50
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $2.12M | 0.29% |
+127,520
| New | +$2.12M |
|